PERCUTON
Airways Clearence Therapy
Percuton is intended for the treatment of pulmonary diseases and lung complications present in out-patient and in-patient departments settings. PERCUTON generates electric signals, which are subsequently converted to high-intensity acoustic waves, in the low-frequency audio range, through two hand-held emitters. The emitters are applied to the surface of the chest, where the acoustic waves then propagate to the lungs, causing vibrations of the lung parenchyma. The frequency of the signal constantly changes frequency (range of 20-300 Hz), thus creating a number of effects such as resonance.
Pathological:
Vibro-acoustic therapy for lungs is appropriate for conditions associated with hyperproduction and the impaired evacuation of bronchial mucus, such as:
- Exacerbation of COPD
- Hyper-productive bronchitis
- Bronchiectatic disease
- Bronchial asthma
- Cystic fibrosis
- Depressed coughing reflex in neurology and other conditions
Feature
- 10 pre-programmed programmes adapted to different pulmonary pathologies
- Variable frequency modulation
- Automatic intensity correction according to patient category
- Acoustic vibration with three therapeutic effects: improved bronchial drainage, normalisation of ventilation-perfusion ratios, and opening of microatelectasis.
- Emitters: Two manual chest-wall emitters
- Interface & Controls: Touchscreen control
Technical specifications general
- Vibration Frequency Range: 20–300 Hz (complex acoustic vibrations
- Signal Type: High-intensity acoustic waves converted from electrical signals with constantly changing frequency for resonance
- Session Duration: 5–10 minutes outpatient session
- Regulatory Status: CE-marked medical device

